UK markets closed

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.85+0.20 (+0.48%)
As of 12:42PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5576
Avg. Estimate-0.67-0.69-2.92-3.05
Low estimate-0.76-0.74-3.55-3.93
High estimate-0.52-0.57-2.28-1.76
Year ago EPS-0.65-0.81-2.92-2.92
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4476
Avg. Estimate920k940k3.06M2.76M
Low estimateN/AN/AN/AN/A
High estimate1.6M1.7M6.5M6.5M
Year ago sales268k1.52M6.88M3.06M
Sales growth (year/est)243.30%-38.00%-55.50%-9.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.67-0.68-0.74-0.69
Actual EPS-0.65-0.81-0.83-0.56
Difference0.02-0.13-0.090.13
Surprise %3.00%-19.10%-12.20%18.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.67-0.69-2.92-3.05
7 days ago-0.71-0.72-3.01-3.09
30 days ago-0.71-0.72-3.01-3.09
60 days ago-0.75-0.75-3.12-3.21
90 days ago-0.74-0.77-3.1-3.23
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1111
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCLDXIndustrySector(s)S&P 500
Current qtr.-3.10%N/AN/AN/A
Next qtr.14.80%N/AN/AN/A
Current yearN/AN/AN/AN/A
Next year-4.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A